Epoch Investment Partners’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-952,167
Closed -$33.6M 281
2015
Q1
$33.6M Buy
952,167
+27,630
+3% +$935K 0.13% 128
2014
Q4
$29.7M Sell
924,537
-3,680
-0.4% -$106K 0.11% 133
2014
Q3
$26M Sell
928,217
-355,395
-28% -$10.8M 0.1% 139
2014
Q2
$38.8M Sell
1,283,612
-84,066
-6% -$2.32M 0.15% 121
2014
Q1
$37.9M Buy
1,367,678
+47,160
+4% +$1.23M 0.15% 130
2013
Q4
$33.7M Buy
1,320,518
+419,235
+47% +$12.9M 0.14% 133
2013
Q3
$26.9M Buy
901,283
+83,190
+10% +$2.31M 0.12% 140
2013
Q2
$23.5M Buy
+818,093
New +$22.5M 0.12% 147

Other funds holding BRLI

Epoch Investment Partners's BRLI Position: Q2 2015 in Review

Epoch Investment Partners sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 952,167 shares — an estimated $33.6M sold.

Epoch Investment Partners first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $38.8M in Q2 2014. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • Epoch Investment Partners reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • Epoch Investment Partners sold 952,167 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $33.6M.
  • Epoch Investment Partners first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
  • Epoch Investment Partners's BIO-REFERENCE LABS INC-NEW- position peaked at $38.8M in Q2 2014.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Epoch Investment Partners's 13F filing for Q2 2015, filed 13 Aug 2015.